Kolexia
Dourthe Louis Oncologie médicale
Dourthe Louis
Oncologie médicale
Clinique Saint-luc
Schirmeck, France
112 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinomes Métastase tumorale Tumeurs de la prostate Néphrocarcinome Tumeurs prostatiques résistantes à la castration Tumeurs du côlon Carcinome transitionnel Tumeurs de la vessie urinaire

Collaborateurs

Voir plus
Barthelemy Philippe
Barthelemy Philippe
Hôpital Civil, Strasbourg, France
Escande Anne
Escande Anne
Clinique Saint-luc, Schirmeck, France
Mineur Laurent
Mineur Laurent
Centre Hospitalier de Apt, Apt, France
Thiery-Vuillemin Antoine
Thiery-Vuillemin Antoine
Le Mittan Annexe Du Hnfc, Montbéliard, France

Industries

Voir plus
A+A
116 collaboration(s)
Dernière en 2023
B3TSI
38 collaboration(s)
Dernière en 2023
Zeste Research
32 collaboration(s)
Dernière en 2021
Janssen
18 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ORHEO: Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Essai Clinique (Pfizer)   26 février 2024
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley): A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)
Essai Clinique (Emd Serono)   05 février 2024
IDEA: A Phase III Randomized Trial Investigating the Duration of Adjuvant Therapy(3 Versus 6 Months) With the Modified FOLFOX 6 or XELOX Regimens for Patients With Stage III Colon Cancer
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   27 septembre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100): A PHASE 3, MULTICENTER, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, PARALLEL-ARM STUDY OF AVELUMAB (MSB0010718C) PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE AS A MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER WHOSE DISEASE DID NOT PROGRESS AFTER COMPLETION OF FIRST-LINE PLATINUM-CONTAINING CHEMOTHERAPY
Essai Clinique (Pfizer)   02 juin 2023
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable): A Double-blind Randomised Phase III Trial Evaluating the Efficacy of ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability and Not Elected for Docetaxel or Androgen Receptor Targeted Agents
Essai Clinique (Bayer)   10 mai 2023
DONEPEZOX: Evaluation of the Efficacy of Donepezil in the Treatment of Oxaliplatin-induced Peripheral Neuropathy: Proof of Concept Study
Essai Clinique (CHU Clermont-Ferrand)   25 avril 2023
321P A comprehensive predicting model of recurrence in stage III colon cancer from PETACC-8 trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Metastatic renal cell carcinoma: Management of toxicities of combinations.
Bulletin du cancer   21 juin 2022